Bidding 18-22 Jun 2026, price band ₹196–208, lot 600 shares.
GMP last updated: 25 Jun 2026, 9:36 AM IST
| Date | GMP (₹) | Est. Listing Price (₹) | Est. Listing Gain |
|---|---|---|---|
| 24 Jun | ₹145 | ₹353 | 69.71% |
| 23 Jun | ₹145 | ₹353 | 69.71% |
| 22 Jun | ₹95 | ₹303 | 45.67% |
| 21 Jun | ₹72 | ₹280 | 34.62% |
| 20 Jun | ₹70 | ₹278 | 33.65% |
| 19 Jun | ₹85 | ₹293 | 40.87% |
| 18 Jun | ₹85 | ₹293 | 40.87% |
| 17 Jun | ₹85 | ₹293 | 40.87% |
| 16 Jun | ₹75 | ₹283 | 36.06% |
| 15 Jun | ₹63 | ₹271 | 30.29% |
| 14 Jun | ₹70 | ₹278 | 33.65% |
| 13 Jun | ₹0 | ₹208 | 0.00% |
| 12 Jun | ₹0 | ₹208 | 0.00% |
After allotment
| Category | Times | Est. Allotment Chances* |
|---|---|---|
| HNIs (Total) | 597.17🔥 | 0.17% |
| bHNI | 670.18🔥 | 0.15% |
| sHNI | 451.17🔥 | 0.22% |
| QIBs | 196.77🔥 | - |
| Retail | 399.89🔥 | 0.25% |
| Total | 384.57🔥 | - |
*Rough estimate: 1 ÷ times subscribed. Retail and HNI allotment is by lottery, so actual odds depend on the number of applications.
Avience Biomedicals Limited is an Indian healthcare products company engaged in the manufacturing and supply of diagnostic kits, medical devices and related healthcare products. The company began its operations with diagnostic solutions such as Viral Transport Media (VTM) and test kits for diseases including COVID-19, HIV, HBsAg, malaria and dengue. Over time, it expanded its portfolio to include in-vitro diagnostic (IVD) rapid test kits, serology products, biochemistry analysers and biochemistry reagents. The company serves the healthcare sector by providing products used in disease detection, diagnosis and laboratory testing. Its revenue is primarily generated through the sale of these diagnostic and medical device products. Avience Biomedicals operates in the medical devices and diagnostics segment and focuses on offering healthcare solutions across multiple testing and diagnostic categories.